PEG length effect of peptide-functional liposome for blood brain barrier (BBB) penetration and brain targeting
Authors:
- 14 June 2024
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 372, 85-94
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Advanced strategies to evade the mononuclear phagocyte system clearance of nanomaterialsExploration, 2023
- Brain co‐delivery of first‐line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapyExploration, 2022
- To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternativesAdvanced Drug Delivery Reviews, 2021
- Tuning the Elasticity of Polymersomes for Brain Tumor TargetingAdvanced Science, 2021
- Systemic Brain Delivery of Antisense Oligonucleotides across the Blood–Brain Barrier with a Glucose‐Coated Polymeric NanocarrierAngewandte Chemie International Edition, 2020
- Ligand‐Installed Nanocarriers toward Precision TherapyAdvanced Materials, 2019
- PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolutionDrug Delivery and Translational Research, 2019
- Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic NanomedicineAdvanced Materials, 2018
- PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene deliveryActa Biomaterialia, 2016
- Liposomal drug delivery systems: From concept to clinical applicationsAdvanced Drug Delivery Reviews, 2013